Slingshot Insights | Rgls Overview

RGLS Overview

Upcoming Projects (RGLS)

Don’t see a project related to the company you care about? Create your own!

Executed Projects (RGLS)

Exploring the potential of Regulus Therapeutics’ RNA-Targeted Drug RGLS8429 in autosomal dominant polycystic kidney disease (ADPKD)
Tickers: RGLS, NVS
Executed On: May 15, 2025 at 01:00 PM EDT
Discussing autosomal dominant polycystic kidney disease (ADPKD) and the potential of Regulus' RGLS8429
Ticker: RGLS
Executed On: Mar 29, 2023 at 02:00 PM EDT

Upcoming & Overdue Catalysts (RGLS)

Don’t see a catalyst related to the company you care about? Create your own!

Occurred Catalysts (RGLS)

Regulus receives FDA requirements for resolving clinical hold on lead product candidate RG-101, information to be submitted in Q4
Ticker: RGLS
Occurred on: Jul 27, 2016
Regulus Reports Clinical Hold of RG-101
Ticker: RGLS
Occurred on: Jun 27, 2016
Regulus Reports Positive Top-line Data from the primary endpoint analysis of one of the company's ongoing Phase II studies of RG-101 for the treatment of Hepatitis C Virus infection (HCV)
Ticker: RGLS
Occurred on: Jun 07, 2016
Regulus to Present New RG-012 Data at The 53rd European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Congress
Ticker: RGLS
Occurred on: May 22, 2016

Strategic Initiatives (RGLS)

Don’t see a strategic initiative related to the company you care about? Create your own!